Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03298945 · ClinicalTrials.gov registry record · Phase 4
Comparative Effectiveness of Split-Dose Colonoscopy Bowel Preparation Regimens
A Phase 4 study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 4
- Development phase
- 2,239
- Enrollment target
NCT03298945: Completed Phase 4 study, sponsored by VA Office of Research and Development.
NCT03298945 is a Phase 4 study that has completed, run by VA Office of Research and Development. The registered enrollment target is 2,239 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03298945, a Phase 4 study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 2,239 participants
- Enrollment target
Study Summary
From the patients' perspective, the most formidable part of the colonoscopy experience is the process of bowel cleansing. A poorly tolerated bowel preparation regimen often leads to incompletion of scheduled colonoscopies which in turn undermines the effectiveness of colonoscopy, increases cost, and decreases patient satisfaction. The current standard bowel preparation in the VA is of larger volume and less palatable than another commonly used bowel preparation regimen. The investigators propose to compare these two commonly used bowel preparations with respect to the overall completion rate of scheduled colonoscopies in a real-world VA practice setting. The results of the study can be immediately applied to maximize the effectiveness of colonoscopy and increase patient satisfaction in the VA.
Interventions
- DRUG Golytely
- DRUG Miralax-Gatorade Prep
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,239 participants |
| Start Date | 2018-12-13 |
| Est. Completion | 2024-06-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03298945
The ClinicalTrials.gov registry entry for NCT03298945 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 2,239 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Golytely is the first listed.
NCT03298945 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03298945 about?
NCT03298945 is a clinical study titled "Comparative Effectiveness of Split-Dose Colonoscopy Bowel Preparation Regimens". From the patients' perspective, the most formidable part of the colonoscopy experience is the process of bowel cleansing. A poorly tolerated bowel preparation regimen often leads to incompletion of scheduled colonoscopies which in turn undermines the effectiveness of colonoscopy, increases cost, and...
What is the current status of trial NCT03298945?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 2,239 participants. The study started on 2018-12-13. Estimated completion is 2024-06-30.
What interventions are being tested in trial NCT03298945?
The interventions under investigation include: Golytely (DRUG), Miralax-Gatorade Prep (DRUG).
Who is sponsoring clinical trial NCT03298945?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.